Cite
Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan.
MLA
Kubota, Sodai, et al. “Association of Dipeptidyl Peptidase‐4 Inhibitor Use and Risk of Pancreatic Cancer in Individuals with Diabetes in Japan.” Journal of Diabetes Investigation, vol. 14, no. 1, Jan. 2023, pp. 67–74. EBSCOhost, https://doi.org/10.1111/jdi.13921.
APA
Kubota, S., Haraguchi, T., Kuwata, H., Seino, Y., Murotani, K., Tajima, T., Terashima, G., Kaneko, M., Takahashi, Y., Takao, K., Kato, T., Shide, K., Imai, S., Suzuki, A., Terauchi, Y., Yamada, Y., Seino, Y., & Yabe, D. (2023). Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan. Journal of Diabetes Investigation, 14(1), 67–74. https://doi.org/10.1111/jdi.13921
Chicago
Kubota, Sodai, Takuya Haraguchi, Hitoshi Kuwata, Yusuke Seino, Kenta Murotani, Takumi Tajima, Gen Terashima, et al. 2023. “Association of Dipeptidyl Peptidase‐4 Inhibitor Use and Risk of Pancreatic Cancer in Individuals with Diabetes in Japan.” Journal of Diabetes Investigation 14 (1): 67–74. doi:10.1111/jdi.13921.